Federal Hemp (2018 Farm Bill) vs State Hemp Restrictions
Side-by-side analysis of Federal Hemp (2018 Farm Bill) and State Hemp Restrictions for cannabis business strategy, with a decisive recommendation from Hoban Law Group.
Side-by-Side Comparison
| Factor | Federal Hemp (2018 Farm Bill) | State Hemp Restrictions | Verdict |
|---|---|---|---|
| Legal status | Federally legal — removed from CSA Schedule I if <0.3% THC | Variable — some states restrict hemp and hemp-derived products | Federal Hemp (2018 Farm Bill) wins The 2018 Farm Bill federally legalized hemp and hemp-derived products, but states retain authority to impose their own restrictions on hemp commerce within their borders. |
| Interstate commerce | Permitted — hemp can cross state lines lawfully | Restricted — state bans apply to hemp entering or sold within that state | Federal Hemp (2018 Farm Bill) wins The federal legality of hemp enables interstate commerce, a fundamental difference from cannabis. However, state restrictions on hemp products affect what can be sold within state borders. |
| Intoxicating hemp products | Federally legal if <0.3% Delta-9 THC — Delta-8 and HHC in gray area | Many states restrict Delta-8, HHC, THCA, and other intoxicating hemp derivatives | Depends The 2018 Farm Bill's Delta-9 THC threshold has enabled a market in intoxicating hemp-derived products that many states are actively restricting. |
| Regulatory framework | USDA regulates cultivation; FDA has authority over products; CBD food use unresolved | State agriculture and health departments regulate; restrictions vary widely | State Hemp Restrictions wins The federal hemp regulatory framework has significant gaps — FDA has not issued comprehensive product rules — creating a patchwork that state regulations partially fill. |
| Banking access | Full banking access for hemp businesses — federally legal | Same banking access — state restrictions do not affect federal banking status | Federal Hemp (2018 Farm Bill) wins Hemp businesses have full access to the conventional banking system, a critical operational advantage over cannabis businesses that continue to face banking restrictions. |
| Market disruption potential | High — hemp-derived THC products compete with licensed cannabis at fraction of regulatory cost | State restrictions limit this disruption within state borders | State Hemp Restrictions wins Hemp-derived intoxicating products (Delta-8, HHC, THCA flower) compete with licensed cannabis without the licensing costs, taxes, or 280E burden, disrupting cannabis operator economics in states where hemp derivatives are permitted. |
Federal Hemp (2018 Farm Bill) vs State Hemp Restrictions: Regulatory Analysis
The 2018 Farm Bill's legalization of hemp with less than 0.3% Delta-9 THC created an unexpected regulatory environment that has significantly disrupted the licensed cannabis industry. Understanding the interplay between federal hemp law and state hemp restrictions is essential for operators in both industries.
What the 2018 Farm Bill Did
The Agriculture Improvement Act of 2018 (the "Farm Bill") removed hemp from Schedule I of the Controlled Substances Act, defining hemp as cannabis sativa with a Delta-9 THC concentration of 0.3% or less on a dry weight basis. This federal legalization enabled commercial hemp cultivation, interstate commerce in hemp and hemp-derived products, and full banking access for hemp businesses.
The practical consequence that the Farm Bill's drafters may not have fully anticipated: a market in intoxicating hemp-derived products. Delta-8 THC, Delta-10 THC, HHC, THCA (which converts to Delta-9 THC when heated), and numerous other cannabinoids can be synthesized or concentrated from federally legal hemp in ways that produce intoxication comparable to cannabis — but without the licensing costs, taxes, or 280E tax burden that licensed cannabis operators bear.
State Responses: A Patchwork of Restrictions
States have responded to intoxicating hemp products in dramatically different ways. Some states have maintained relatively open frameworks that permit the sale of Delta-8 and similar products. Others have enacted legislation banning or strictly regulating hemp-derived intoxicants, typically arguing that these products were not contemplated by the Farm Bill and create consumer safety concerns.
As of 2026, the state regulatory map for hemp-derived intoxicating products changes frequently. Operators in the hemp-derived intoxicants market must track state law changes on a continuous basis.
Impact on Licensed Cannabis Operators
For licensed cannabis operators, hemp-derived intoxicating products are an existential competitive threat. A Delta-8 THC product sold from a gas station or convenience store in a state that permits it faces no licensing costs, no excise taxes, and no 280E burden — while competing directly with licensed cannabis products on the dispensary shelf. Cannabis industry advocates have argued strenuously for either federal restriction of intoxicating hemp derivatives or equity treatment that subjects hemp-derived THC to comparable taxation and regulation as cannabis.
Decision framework
Which fits your business?
What does this mean for your business? If you are a licensed cannabis operator, intoxicating hemp derivatives are a regulatory arbitrage that your competitors exploit without your cost structure. Advocating for state and federal hemp regulation is a legitimate business priority, and Hoban Law Group has represented cannabis industry clients in state legislative proceedings on this issue. If you are a hemp business operator, you should be tracking state restriction developments closely — the window for freely distributing intoxicating hemp products is narrowing as more states enact restrictions, and the federal Farm Bill reauthorization is an opportunity for Congress to address this gap. [Schedule a consultation](/consultation?source=compare&compare=federal-hemp-2018-farm-bill-vs-state-hemp-bans&matter_type=regulatory-compliance).
Frequently Asked Questions
- Is Delta-8 THC legal under federal law?
- The 2018 Farm Bill's definition of hemp does not explicitly address Delta-8 THC, which is synthesized from CBD (itself derived from federally legal hemp) through a chemical conversion process. The DEA has issued letters suggesting Delta-8 THC in synthetic form may be a controlled substance analogue, but federal enforcement has been limited. Many states have moved to explicitly restrict or ban Delta-8 products regardless of federal status.
- Can hemp and hemp-derived products legally cross state lines?
- Hemp products that comply with the Farm Bill definition (Delta-9 THC < 0.3%) can legally cross state lines under federal law. However, state law applies upon arrival — if the destination state restricts the product, state law enforcement can still apply to sales within that state.
- What is THCA flower and why is it controversial?
- THCA (tetrahydrocannabinolic acid) is a non-psychoactive precursor to Delta-9 THC. In its raw form, THCA has low psychoactive effect; when heated (smoked or vaporized), it decarboxylates into Delta-9 THC. THCA flower from hemp can have very high THCA content while remaining below 0.3% Delta-9 THC on a pre-heating test, technically meeting the Farm Bill definition while producing significant intoxication when used. Many states are moving to close this gap.
- How does the Farm Bill reauthorization affect hemp regulations?
- The Farm Bill expires periodically and must be reauthorized. The 2023 Farm Bill reauthorization process included significant debate about intoxicating hemp derivatives. Congress has the authority through Farm Bill reauthorization to modify the definition of hemp, add testing requirements that address THCA conversion, or impose THC testing standards that would restrict intoxicating hemp products. As of 2026, hemp regulatory reform remains an active area of Congressional and agency activity.
Work with Hoban Law Group
Get counsel on your Federal Hemp (2018 Farm Bill) or State Hemp Restrictions matter
Our team prepares a regulatory briefing specific to your matter before you speak with counsel. No cost. No commitment.
Schedule a consultation